Commentary in NEJM Backs Making Hospitals Report Gross Profits from 340B

NEJM
To encourage nonprofit hospitals to do more for their communities, policymakers could examine how hospitals are using their gross profit from the 340B program, an opinion article in The New England Journal of Medicine says.
The 340B drug pricing program has evolved from a “buy low, sell low” program to help safety-net hospitals serve low-income [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Is “Off the Rails,” Civil Rights Leader Chavis Says in Nationally Syndicated Op-Ed

Benjamin Chavis
Health system greed has “made a mockery” of the 340B program, civil rights leader Benjamin Chavis says in nationally syndicated op-ed published by multiple African American news organizations.
Health system greed has “made a mockery” of the 340B drug pricing program and leads to practices that widen health [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

In What Could be a First, Drug Maker Gives Providers Deadline to Request 340B Overcharge Refunds

VistaPharm
Drug manufacturer VistaPharm says requests for refunds for 340B overcharges must be received before Aug. 31. No manufacturer is believed to have set such a deadline before, and it's unclear if VistaPharm is the first to say refunds are available upon request.
Generic and over-the-counter drug manufacturer VistaPharm said in a public notice this week that it has identified 340B covered entities [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Ease 340B Requirements for Generic Drugs to Ease Shortages, Trade Group Tells Congressional Committee Chairs

Pills
Congress should ease 340B requirements for generic drugs to help stem shortages, the trade group for makers of the drugs said in a July 7 white paper.
Low-cost generic drugs should get an exemption from the 340B drug pricing program to help reduce drug shortages, the U.S. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Studies Reach Different Conclusions About Whether Vulnerable Patients Benefit from 340B Savings

340B patient assistance program study
Passing 340B drug discounts to patients with COPD so they can buy inhalers at a much lower cost yielded positive outcomes both for the patients and the hospitals that serve them, new research shows.
Two new studies—one by pharmacists at Ascension Via Christi health system in Kansas, the other by drug industry consulting and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Top Republican on Senate HELP Committee Calls for 340B Transparency and Accountability Action

Bill Cassidy
U.S. Senate HELP Committee ranking Republican Bill Cassidy (La.) said in an op-ed today that Congress should “increase 340B transparency and accountability to preserve the intent of the program.”
U.S. Sen Bill Cassidy (La.), the top Republican on the Senate Health, Education, Labor, and Pensions Committee, said in an [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Group Seeking New 340C Program for Grantees and Rural Hospitals Is Ramping Up Advocacy

340C
More than 100 health centers and groups have signed a letter to Congress supporting the 340C initiative.
The national health center group promoting 340C—a proposed alternative to the 340B drug pricing program for health centers, federal grantees, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

U.S. Rep. Matsui Expected to File 340B Contract Pharmacy Bill in Connection with 340B Conference

Doris Matsui
Rep. Doris Matsui (D-Calif.) introduced federal legislation to prohibit drugmaker 340B contract pharmacy restrictions.

A bill amending the 340B statute to explicitly require drug makers to unconditionally sell and deliver 340B drugs dispensed by contract pharmacies is expected to be introduced just before or during the 340B Coalition summer conference July 10-12 near Washington,

Read More »

Get PBMs to Squeeze 340B Drugs Harder, “Playbook” Advises Employers

NAHPC
A new "playbook" for business-sponsored health plans advises them to press PBMs to do more to ensure that health care purchasers get the benefits of 340B drug discounts.

A new “playbook” for employers on getting the upper hand with pharmacy benefit managers says PBM handling of 340B drugs is a top 10 concern for business-sponsored health plans.

Released yesterday by the Washington, D.C., based National Alliance of Healthcare

Read More »

Hospital Groups to CMS: Don’t Rob Some Hospitals to Repay 340B Hospitals for Your Illegal Drug Payment Cuts

AHA and NRHA
AHA and NRHA both urged the Biden administration not to claw back Medicare payments from some hospitals to pay for the remedy for illegal drug payment cuts for 340B hospitals.

Two hospital groups separately urged Biden administration officials this month to not divert funding from non-340B hospitals and some 340B hospitals in order to repay other 340B hospitals for almost five years’ worth of illegal Medicare Part B drug payment

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live